STRIDEBIO
StrideBio is a gene therapy company focused on developing genetic medicines with curative potential for patients with devastating conditions. It leverages its proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform to create unique and differentiated vectors that improve upon naturally occurring AAV serotypes to overcome current limitations of first-generation gene therapies. The company was founded in 2015 and is headquartered in Durham, North Carolina.
STRIDEBIO
Social Links:
Industry:
Biotechnology Health Care Information Technology Therapeutics
Founded:
2015-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.stridebio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
97.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Northpond Ventures
Northpond Ventures investment in Series B - StrideBio
CaaS Capital Management
CaaS Capital Management investment in Series B - StrideBio
Takeda Ventures
Takeda Ventures investment in Series B - StrideBio
Sarepta Therapeutics
Sarepta Therapeutics investment in Series B - StrideBio
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - StrideBio
Novo Holdings
Novo Holdings investment in Series B - StrideBio
UCB Ventures
UCB Ventures investment in Series B - StrideBio
UF Innovate Ventures
UF Innovate Ventures investment in Series B - StrideBio
Pontifax
Pontifax investment in Series B - StrideBio
Octagon Capital Advisors
Octagon Capital Advisors investment in Series B - StrideBio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-04 | StrideBio Announces Mark Velleca, M.D., Ph.D., as Chief Executive Officer |
Official Site Inspections
http://www.stridebio.com Semrush global rank: 2.23 M Semrush visits lastest month: 8.65 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
